This compound is a boronic ester pharmaceutical intermediate featuring a spirocyclic dioxaborolane structure. It is primarily used as a building block in the synthesis of more complex pharmaceutical compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(2-Fluoro-3-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
pharmaceutical intermediate
Methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
pharmaceutical intermediate
Ethyl 3,3-difluorocyclobutanecarboxylate
pharmaceutical intermediate
(2R,4R)-1-(tert-Butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid
pharmaceutical intermediate
Acarviosine-glucose
pharmaceutical intermediate
4-(4-(4-(Trifluoromethoxy)phenoxy)piperidin-1-yl)phenol
pharmaceutical intermediate
2-(1,4-dioxaspiro[4.5]dec-7-en-8-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
JCHWHOHZZYWUMP-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CCC3(CC2)OCCO3
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.